CliffBio
small molecule

XYLOCAINE W/ EPINEPHRINE

EPINEPHRINE; LIDOCAINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameXYLOCAINE W/ EPINEPHRINE
Active ingredientEPINEPHRINE; LIDOCAINE HYDROCHLORIDE
Strength0.01MG/ML;2%
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
Marketing statusDISCN

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.